In This Section

Precision Combination Therapy Task Force

The AACR Precision Combination Therapy Task Force convenes a diverse group of experts engaged in clinical and translational research to analyze the current state of combination therapies, identify innovative solutions to optimize and standardize clinical trial design, and assist in guiding the AACR’s ongoing and future programs and initiatives to educate and train clinical researchers about the complexities and opportunities of cancer combination therapy trials.


Elizabeth M. Jaffee, MD, FAACR Sidney Kimmel Comprehensive Cancer Center The Johns Hopkins University School of Medicine, Baltimore, Maryland


Jennifer Rubin Grandis, MD, University of California San Francisco, San Francisco, California
Albert C. Koong, MD, PhD, The University of Texas MD Anderson Cancer Center, Houston, Texas
Patricia M. LoRusso, DO, PhD, Yale Comprehensive Cancer Center, New Haven, Connecticut
Antoni Ribas, MD, PhD, FAACR, University of California Los Angeles Medical Center, Los Angeles, California

Contact Information

Kathryn Leonard, PhD
Phone: 215-309-4356
Email: [email protected]